Cancer undetectable for one in 12 patients in daraxonrasib trial, while nearly all participants’ tumours stopped growing

A pill that can shrink and potentially eliminate pancreas tumours is being hailed as the biggest breakthrough treatment for the cancer in decades.

In one in 12 of the patients given the drug, daraxonrasib, during a trial, the cancer became undetectable, and the tumours stopped growing in almost all of the 61 patients. The trial participants had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.

Though doctors have said the pill cannot yet be considered a cure, and they do not know how long it can keep the disease at bay, they have said it is encouraging news because it appears it will offer patients more time, even if it does not cause full remission.

Half of all people diagnosed with pancreatic cancer die within three months, and only about 3% of patients survive for five years when the disease spreads to other organs.

  • Thebeardedsinglemalt
    link
    fedilink
    English
    arrow-up
    3
    ·
    8 hours ago

    My hardcore conservative uncle died less than 2 months ago from pancreatitic cancer. He was on the list to start receiving a recently approved FDA drug, may or may not have been this one, but passed before to the first cycle started.

    Oh well